Top 100 Most-Cited Papers in Herpes Zoster from 2000 to 2022: A Bibliometric Study
Ning Gao,Meng Li,Weiming Wang,Lei Wang,Zhen Liu,Yufeng Guo
DOI: https://doi.org/10.2147/JPR.S409616
IF: 2.8319
2023-05-29
Journal of Pain Research
Abstract:Ning Gao, 1, &ast Meng Li, 2, &ast Weiming Wang, 1 Lei Wang, 3 Zhen Liu, 4 Yufeng Guo 1 1 Department of Acupuncture and Moxibustion, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China; 2 Department of Gastroenterology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China; 3 Department of Dermatology, China-Japan Friendship Hospital, Beijing, 100020, People's Republic of China; 4 Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhen Liu, Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Playground, Haidian District, Beijing, People's Republic of China, Email Yufeng Guo, Department of Acupuncture and Moxibustion, Guang' an Men Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange St., Xicheng District, Beijing, People's Republic of China, Email Background: In recent years, the incidence of herpes zoster has risen steeply, the exact pathogenesis of the acute pain and the transformation into postherpetic neuralgia are still obscure, and the absence of effective management remains a major therapeutic challenge. The purpose of this study was to perform a qualitative and quantitative bibliometric analysis of the 100 most cited papers on herpes zoster. Materials and methods: Related literature were retrieved from the Web of Science Core Collection. Excel and VOSviewer software were applied to quantitatively analyze, and construct the bibliometric network charts. Results: The Top 100 most-cited papers published between 2000 and 2018 showed a fluctuating downward trend. The most studies were published in the year of 2000 (n = 12). The article entitled "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults" from Oxman MN, was the most-cited publication. The United States was the most contributing country, followed by the United Kingdom, and Italy. Finland occupied the highest citations per publication (CPP). The University of Colorado topped the list of institutions with the most publications with 18 articles and also had the most citations (average citations: 281.78 per article). Myron J Levin from the University of Colorado School of Medicine is the most published and most cited researcher overall, whereas Duke University's John W Gnann tops the list in terms of average CPP. Conclusion: In terms of the quantity of T100 articles, researchers, and organizations, the US is the predominant country. The most T100 papers were published in the special journal Clinical Infectious Diseases. The most academic focus remain the remedies for postherpetic neuralgia and vaccine development for individualized groups. Keywords: herpes zoster, bibliometric study, top-cited, citation, VOSviewer Varicella zoster virus (VZV) belongs to the genus varicella virus of the family Herpesviridae and is transmitted in the population mainly through the respiratory tract. 1 It was first isolated in tissue culture in 1953. 2 Herpes zoster (HZ) is a cutaneous disease caused by reactivation of the VZV in the host. 3 When immunity to VZV declines due to aging or immunosuppression, VZV reactivation occurs. 4 The clinical presentation is typically a cluster of rashes and vesicles on a red base in a unilateral, dermatomal distribution, with intense neuralgia along the peripheral nerves near the skin lesion. 4 Some patients may develop systemic symptoms such as nausea, fatigue and fever. 3 The risk of HZ increases with age (>50 years). 5 The classical risk factors also include immunosuppression, infections, and psychological stress. 5 According to the Centers for Disease Control and Prevention (CDC), nearly one out of every three people in the United States will suffer from HZ during their lifetime. 6 An estimated 19.4% of patients with HZ experienced postherpetic neuralgia (PHN), as observed in Chinese outpatients, 7 which is one of the most common complications of HZ, with severe neuralgia in the affected dermatome after the rash recedes. 8 The overall incidence of HZ has linearly increased over the past few decades, most likely due to an aging population and an increase in the number of immunocompromised people, 9 which not only affects the quality of life of patients, but also poses a significant clinical and economic burden. 10,11 Current -Abstract Truncated-
clinical neurology